Second wave anti-HCV protease inhibitors: too little too late?

Liver Int. 2014 Aug;34(7):e168-70. doi: 10.1111/liv.12543.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Hepacivirus / genetics*
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lactams / therapeutic use*
  • Male
  • Polyethylene Glycols / therapeutic use*
  • Ritonavir / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Interferon-alpha
  • Lactams
  • Sulfonamides
  • Polyethylene Glycols
  • Ritonavir